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Environmental tobacco smoke (ETS) is one
ofthe most common indoor pollutants and
is associated with a range ofadverse health
effects in both children and adults (1-6).
We have focused on acute irritant and
rhinitis symptoms ofvariable magnitudes in
healthy nonsmoking adults (1,7) and are
interested in understanding the mechanisms
of increased upper respiratory infections
and increased asthma symptoms among
children (8).
Our previous studies characterized the
acute physiologic and inflammatory response
to sidestream smoke (7,9). ETS is defined as
the tobacco smoke that nonsmokers inhale;
it is composed ofsidestream tobacco smoke
(SS) and exhaled mainstream smoke (MS).
SS is the dominant component ofETS and
can be generated with a smoking machine.
We have examined the response to ETS by
performing controlled human exposure stud-
ies with SS. Subjects with a history of ETS
rhinitis symptoms demonstrate an increased
symptomatic and objective congestive
response to brief, high levels of SS (45 ppm
for 15 min). Both subjects with and without
a history ofETS rhinitis demonstrate a con-
gestive response toprolonged moderate levels
of SS (15 ppm for 2 hr). The congestive
response lasts less than an hour and occurs
without an increase in the permeability of
the nasal vasculature, as indicated by no
change in the concentration of albumin in
the nasal lavage (i). Although the congestive
response subsides within 1 hr after exposure,
patients report symptoms lasting hours to
days after exposure.
Clinically, a reduction in baseline
mucociliary clearance indicates respiratory
tract injury. Clearance ofparticles from the
respiratory tract is an accepted biomarker
of respiratory tract function response to
toxicants (10), and clearance has been
quantified using saccharine, charcoal, and
radio-opaque or radiolabeled tracers (11).
Proctor (11) concluded that a nasal
mucociliary clearance (NMC) <1-2
mm/min was abnormal in healthy adults.
Alterations in particle clearance have been
used to characterize agent toxicity in ani-
mal studies (12). Twenty years ago,
Anderson et al. (13) noted anecdotally that
controlled SO2 exposure caused the great-
est inhibition ofNMC in the human sub-
jects who showed the greatest S02-induced
nasal symptoms. These findings suggested
the broad hypothesis that subjects report-
ing increased symptoms with exposure to
an irritant might have inhibition ofNMC.
The purpose of the present study was to
determine the effects of controlled side-
stream tobacco smoke exposure on NMC
in healthy nonsmokers.
Materials and Methods
Twelve healthy, nonsmoking subjects were
recruited: six had a history ofETS sensitiv-
ity and an objective, congestive response to
controlled challenge with SS, and six had
no history of ETS sensitivity and no con-
gestive response to controlled challenge
with SS. The selection procedure was as
follows: Healthy, nonsmoking, young
adults (ages 18-45) were recruited by
advertising at the University ofMaryland at
Baltimore. "Nonsmoking" was defined as a
lifetime cumulative smoking history of less
than 1 pack-year and no smoking in the last
5 years. Subjects completed a health history
questionnaire, and those with chronic car-
diorespiratory conditions were excluded
from the study. A screening questionnaire
asked subjects to rate their history and
severity ofsymptoms associated with expo-
sure to environmental tobacco smoke on a
0-5 scale (0 = no history ofsymptoms, 1 =
mild symptoms, 3 = moderate symptoms, 5
= severe symptoms). Symptoms of eye,
nose, and throat irritation and headache
that occurred with historical ETS exposure
were summed to calculate a "historical
ETS-irritation index" and symptoms of
nasal congestion, rhinorrhea, sneezing, and
postnasal drip that occurred with historical
ETS exposure were summed to calculate a
"historical ETS-rhinitis index." Subjects
with an ETS-rhinitis index of <1 were
termed "ETS nonsensitive (ETS-NS)"; sub-
jects with an index of>2 were termed "ETS
sensitive (ETS-S)." This subject stratifica-
tion has been used in prior studies at our
research facility (7).
Prospective subjects underwent a
screening challenge with SS (15 ppm CO, 1
hr) at rest. Those with a greater than 35%
increase in nasal resistance were classified as
demonstrating a congestive response to SS,
those with a smaller than 5% increase in
nasal resistance were considered nonrespon-
sive, and those with an increase in nasal
resistance between 5 and 35% were consid-
ered indeterminate. The 12 subjects were
also characterized with a history, nasal
inspection, baseline nasal and lung func-
tion, methacholine reactivity, and skin-
prick test (1). Stratification was performed
before controlled SS challenge followed by
measurement of NMC. Subjects from the
two groups were interspersed and data col-
lection analysis and reduction completed
before comparison of group differences.
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The order ofthe study days was varied and
study days were separated by at least 1
week. Figure 1 shows the study protocol.
An environmentally controlled research
exposure chamber was used to limit expo-
sure to the desired pollutant and to provide
constant conditions oftemperature (22.2 ±
0.5°C) and relative humidity (40 ± 2%).
The environmental chamber air supply
consisted of ambient air passed through
high-efficiency particulate absolute
(HEPA) filters to remove particles and acti-
vated carbon filters to remove gaseous pol-
lutants. The environmental chamber con-
sisted of a 41-im3 clean room and a 22.2-
m3 exposure room. A ventilation rate of
3.0 m3/min in the exposure room enabled
a complete air change every 7.5 min. All air
in the exposure room was exhausted to the
outside without recirculation.
Reference cigarettes 2R1F (Tobacco
and Health Institute, Lexington,
Kentucky) were used for smoke generation,
and SS was generated in a smoking cham-
ber adjacent to the exposure room. The
generation system consisted of a 4.4-ft3
Plexiglass box containing three manifolds
connected to a timing device. Intermittent
puffs were generated by sequentially open-
ing solenoid valves connected to each man-
ifold to achieve a negative pressure puffon
the filter end of the cigarettes. Human
smoking patterns were simulated by using a
2-sec puffduration at a vacuum pressure of
13.7 cm H20 to produce a 35-cc volume
of draw on each cigarette at 1-min inter-
vals. Mainstream smoke was exhausted to
outside the building. Sidestream smoke was
introduced into the exposure chamber
through a ceiling diffuser and allowed to
exit the chamber without recirculation.
Burning cigarettes were replaced approxi-
mately every 10 min during the study.
Levels of SS were characterized by carbon
monoxide (CO) concentration in the expo-
sure room, which was monitored continu-
ously with an Ecolyzer Series 2100 CO
Meter (Energetics Science, New York) and
with a Bendix Model 8501-5CA Infrared
Gas Analyzer (Bendix Instruments,
Lewisburg, West Virginia). A target con-
centration of 15 ppm CO was achieved by
controlling the number of cigarettes
puffed. Subjects entered the exposure room
after the target smoke concentration was
reached. Particle concentrations and distri-
bution from 0.3 to greater than 10 pm
(Climet Model 226-210 Multi-channel
Particle Analyzer; Climet Instruments Inc.,
Redlands, California) and total organic
vapors (HNU-PI101, HNU, Inc.,
Charlemont, Massachusetts) were also
measured during selected exposures. The
organic vapor meter was calibrated daily
CD X" + + c", cm CDc
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Figure 1. Protocol. Each subject was studied on 2 days, separated by at least 1 week, and exposed to
clean air or sidestream tobacco smoke at a concentration of 15 ppm carbon monoxide. Nasal physiology
measurements included symptoms measurements, posterior rhinomanometry and acoustic rhinometry
and confirmed resolution of nasal congestion before aerosol delivery. The 99mTc-sulfur colloid aerosol
was delivered 1 hr after completion ofthe smoke exposure.
with 100 ppm isobutylene. Clean-air expo-
sures were conducted in an identical man-
ner except that cigarettes were not burned.
We began to assess NMC 50 min after
completion of smoke or air exposure, that
time at which the acute nasal congestive
response to smoke had resolved. An aerosol
(colloidal 99mTc-sulfur in normal saline;
Syncor, Timonium, Maryland) was deliv-
ered to the nasal mucosa, with the catheter
tip positioned 0.3 cm anterior to the inferi-
or turbinate. A scintillation detector,
placed anterior to the subject, made serial
counts for 60 min at 2-min intervals for 30
sec each. Juxtaposing marks on the face
and detector ensured consistent alignment.
Values were normalized to the initial count
and expressed as percent tracer remaining
at each time point. Between 40 and 50
min after exposure, the activity remaining
in each region of the nasal passage was
measured using acollimated detector.
The conditions of aerosol administra-
tion were developed to effect diffuse depo-
sition in the upper respiratory tract. Five
additional subjects were recruited to exam-
ine the initial pattern of tracer deposition.
The four additional detectors needed to
make this assessment were not available at
the time of the initial protocol, but these
five subjects met the entry criteria for the
initial part of the study. Subjects under-
went measurements immediately after
administration of the aerosol to the left
nasal passage. The measurements were
made with the detector in four positions:
centered at 2.5 cm, 3.5 cm, 7.5 cm, and
10.5 cm posterior to the tip of the nose.
Deposition was expressed as a percentage of
the counts measured from the anterior
position. In the five pilot subjects, the
activity measured by the anterior detectors
was 26 ± 9% and deposition in the posteri-
or two detectors was 18 ± 11% ofthe ante-
rior detector counts.
Statistical analyses (ANOVA) were per-
formed with Excel (Microsoft Corp.,
Redmond, Washington). Because the ETS-
S and ETS-NS groups were selected and
stratified in advance ofthe study, the effect
ofsmoke on NMC was analyzed separately
for each group.
Results
Table 1 shows the characteristics and nasal
dimensions ofsubjects at the time oftracer
administration (1 hour after air or smoke
exposure).
Figure 2 shows the average NMC
curves for the ETS-NS and ETS-S subjects.
All subjects showed smooth decay curves,
indicating consistent positioning and
reproducible measurements. After clean-air
exposure, the percent tracer remaining was
similar in the two groups (ETS-NS 51 ±
14% versus ETS-S 41 ± 10%, nonsignifi-
cant). After smoke exposure, the ETS-NS
subjects showed accelerated NMC, with
only 15 ± 3% tracer remaining (ETS-NS,
air versus smoke, p<0.05). In contrast, the
ETS-S subjects had no change in mean
clearance, with 46 ± 13% of the tracer
remaining (ETS-S air versus smoke, p =
0.86).
Figure 3 shows the individual subject
data 40 min after tracer administration. Six
of 12 subjects showed accelerated clearance
(>35% less tracer remaining after smoke
exposure than after air exposure). Three of
12 fast-clearing subjects showed no change
after smoke exposure comparedwith NMC
on air-exposure days (<30% remaining on
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Table 1. Nasal dimensions when radioactive aerosol was delivered tothe nasal passage and activity
remaining at40 min after exposurea
Subject % Activity
no. Characteristicsb Exposure remaining Area
ETS sensitive/SS responsived
1 F,26,NA Air 65 1.1
Smoke 26 0.7
2 M,23,NA Air 84 0.7
Smoke 49 0.7
3 F, 26,A Air 67 0.4
Smoke 96 0.3
4 F,21,NA Air 23 0.4
Smoke 51 0.5
5 M,24,NA Air 40 0.4
Smoke 91 0.5
6 M,24,NA Air 78 0.9
Smoke 24 0.7
ETS nonsensitive/SS nonresponsive
7 M,24,A Air 25 0.5
Smoke 21 0.5
8 F,27,A Air 68 1.1
Smoke 12 1.2
9 F,28,A Air 87 0.4
Smoke 14 0.5
10 F,25,A Air 85 0.9
Smoke 26 0.8
11 F,24,NA Air 26 0.7
Smoke 10 0.7
12 F,25,NA Air 7 0.7
Smoke 8 0.4
aValues shown are the dimensions ofthe nasal passage in which the
bSex, age in years; A, atopic as determined by a positive wheal-and
pricktests; NA, nonatopic as determined by a negative response to si
cMinimum nasal passage cross-sectional area.
dSensitive/responsive subjects reported a history of rhinitis symptom,
exposure (ETS sensitive) and demonstrated increased nasal resistar
sidestream tobacco smoke (SS responsive).
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Figure 2. Total mucociliary clearance. (A) Results forthe environmen
subjects (n = 6) and (B) results for nonsensitive (ETS-NS) subjects (
and after smoke exposure are shown. Values are means ± SEM of c
sec per count. Clearance was normalized to the initial count. At 58 r
formed, demonstrating that on all days only a small quantity ofthe tra
ANOVA: ETS-NS nasal mucociliary clearance (NMC) post-air vs. E
ETS-S NMC post-air vs. ETS-S NMC post-smoke, p = 0.86; NMC po0
significant.
Volume (cm3)
c Anterior Mid
3.5 32.3
2.0 12.5
2.5 27.2
2.2 22.0
1.0 15.8
0.7 20.8
1.1 05.1
1.6 05.3
1.4 14.8
1.6 16.7
2.2 13.1
1.7 10.6
both days).Three of 12 subjects (all ETS-S)
showed substantially increased retention
(>25% more tracer remaining after smoke
exposure than after air exposure). The three
subjects showing reduced clearance with
smoke compared to air exposure were sub-
ject nos. 3, 4, and 5. There was no signifi-
cant correlation between the activity
remaining at 40 min and the nasal dimen-
sions at the time ofaerosol administration.
Figure 4 shows the regional distribution
oftracer 40 min after exposure in ETS-NS
and ETS-S subjects. On average, ETS-S
subjects showed increased retention oftrac-
er at all sites in the nasal passage after
smoke exposure.
Discussion
1.3 15.2 ETS is one ofthe most common indoor air
1.6 17.3 pollutants, and understanding susceptibili-
3.7 29.5 ty to its adverse effects is ofscientific inter-
3.5 35.0 est and public health importance. The pre-
1.0 08.7 sent data indicate that exposure to SS at
1.8 14.8 levels similar to smoky, poorly ventilated
2.1 14.6 rooms causes variable effects on NMC of
2.1 15.7 healthy human subjects (14). The majority
2.1 18.3 of the subjects demonstrated acceleration
2.5 35.8 of NMC with SS exposure or maintained
1.1 10.7 rapid clearance. However, in 3 of the 12
traceraerosolwas delivered. subjects, acute, controlled sidestream
-flare response to one or more skin- tobacco smoke exposure resulted in a sub-
kin-prick tests. stantial reduction in NMC.
The nasal mucociliary clearance system s with environmental tobacco smoke used in this studywas designedto aerosolize
the tracer throughout the nasal passage.
This allows a search for either diffuse or
focal effects within the nasal cavity. Animal
toxicology studies show that mucosal
lesions ofthe nasal passage differ in the site
and type of lesion depending on the toxin
(12). Other methods to assess mucociliary
function, such as the saccharine, charcoal,
B 1l and radio-opaque disc methods, only assess
l Clean air I11 Sidestreamsmoke clearance in a single stream from the inferi-
or turbinate to thepharynx (4).
Aprevious study examined the effect of
exhaled mainstream smoke on nasal
mucociliary dearance of nonsmokers (15).
Ten healthy, nonsmoking volunteers
smoked two cigarettes each, exhaling the
smoke through their nostrils. There was no
acute change in their nasal mucociliary
function as detected by the mean ciliary
20040 60 80 beat frequency or mean nasal mucociliary
clearance. Nasal mucociliary clearance was
also studied in three donkeys exposed to
tobacco smoke (8); no acute change in
tal tobacco smoke-sensitive (ETS-S) clearance occurred.
n= 6). Clearance after air exposure Mucociliary clearance is an aggregate
,ounts made at 2 min intervals for 30
min an anterior nasal wipe was per- measure muosoal function a
icerwas located inthe nasal antrum. (10). Determinants of normal function
-TS-NS NMC post-smoke, *p<0.005; include the quantity and composition of
st-clean air ETS-S vs. ETS-NS, non- airway surface fluid and the type and func-
tion of epithelial cells, especially ciliated
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Figure 3. Activity remaining in the nasal passage 40 mi after exposure. (A) Results for the environmental
tobacco smoke-sensitive (ETS-S) subjects (n =6) and (B) results for the nonsensitive (ETS-NS) sublects (n
=6).
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Figure 4. Distribution of activity remaining in the nasal passage. (A) Results for the environmental tobacco
smoke-sensitive (ETS-S) subjects (n = 6) and (B) results for the environmental tobacco smoke nonsensi-
tive (ETS-NS) subjects (n = 6). Total ETS-NS nasal mucociliary clearance (NMC) post-air vs. ETS-NS NMC
post-smoke, p
= 0.06; ETS-S NMC post-air vs. ETS-S NMC post-smoke, nonsignificant.
cells (12). Animal and in vitro studies indi-
cate that airway cells may potentially be
altered by cigarette smoke (12), although
exposure levels used for animal studies were
typically higher than those used in this
study. In rodent models, tobacco smoke has
been shown to cause acute increases in vas-
cular permeability via activation of upper
respiratory capsaicin-sensitive neurons, an
effect that could increase airway surface
fluid. However, previous human studies in
our laboratory failed to show evidence for
increased nasal vascular permeability with
smoke exposure at these levels (7,16).
Studies of dogs have demonstrated an
effect of stimulation of c-fiber neurons on
ciliary beat frequency (17). These studies
are relevant to the present study, as investi-
gators have demonstrated that the acute
response to tobacco smoke in the upper
respiratory tract of rodents occurs via acti-
vation of capsaicin-sensitive, c-fiber nerves
(18,19). In the dogs, capsaicin, adminis-
tered as an aerosol for 2 min, stimulates an
increase in ciliary beat frequency. This
effect is partially blocked by prior adminis-
tration of indomethacin (a cyclooxygenase
pathway inhibitor), ipratropium bromide
(a muscarinic receptor antagonist), and
hexamethonium bromide (a nicotinic
receptor antagonist). The time course of
the increase in ciliary beat was observed to
include an early phase, lasting 15 min, and
a subsequent phase, lasting 30 minutes
(17). These data suggest that activation of
the chemosensitive nerves with sustained
increases in ciliary beat frequency could
account for the increased mucociliary clear-
ance observed in six of the subjects in this
study.
The inhibition of NMC in three sub-
jects after smoke exposure is of particular
interest. Nasal dimensions at the time of
NMC measurement were similar on the 2
study days, making differences in initial
tracer deposition unlikely. Small changes in
NMC related to cyclic changes in nasal
passage volume are also unlikely to account
for the effects seen. Upper respiratory
responses to numerous toxicants are quali-
tatively similar between humans and many
experimental animals (10,20,21), and the
mechanisms of mucociliary clearance are
thought to be similar in humans and most
other mammals. Animal studies have
shown that low-level irritant exposure
accelerates mucociliary clearance.
Acceleration of NMC has been demon-
strated in humans with exercise (attributed
to adrenergic stimulation), nasal saline
flush (attributed to increased surface fluid),
and pharmacologic agents such as s-ago-
nists and cholinergic agonists.
Animal studies have shown that higher-
level irritant exposure inhibits mucociliary
clearance (12,22). Our data suggest a possi-
ble leftward shift in the exposure-response
curve in some of our subjects. Possible
mechanisms for the reduction in NMC
include include inhibition of ciliary beat-
ing, altered viscoelastic properties or reduc-
tions in airway surface fluid (13,22). In
human studies, few stimuli other than
extreme dehydration markedly inhibit
NMC (11).
Other investigators have assessed the
effects of active smoking on baseline nasal
mucociliary clearance (15). A comparison
of nonsmokers and smokers showed that
28 current smokers had a mean clearance
time of 20.8 min, which was significantly
longer than the mean time of 11.8 min in
27 lifelong nonsmokers. One smoker (not
included in the average) had a clearance
>60 min. There was no significant differ-
ence between the mean nasal ciliary beat
frequency of 10 smokers and 10 nonsmok-
ers (measured on nasal scrapings). The
investigators interpreted this as evidence
that the periciliary environment (e.g., sur-
face fluid and mucus rheology) were
responsible for the impaired clearance and
that a direct ciliary toxicity was less likely.
Studies of young smokers showed various
degrees of impairment of tracheal mucous
velocity before the onset of bronchitis
symptoms or evidence of airway obstruc-
tion via pulmonary function tests (10,23).
The clinical significance of these find-
ings remains to be determined. We specu-
late that the subjects with inhibition of
nasal mucociliary clearance after smoke
exposure are at increased risk of chronic
airway injury for two reasons. First,
mucociliary clearance is an accepted bio-
marker of pulmonary function (10), and
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clearance is maintained in the face ofmany
insults. Inhibition of clearance suggests a
greater degree of injury than unaltered or
accelerated clearance. Second, impaired
mucociliary clearance has been associated
with increased rates of infection and aller-
gy, and these processes could produce fur-
ther injury. Cystic fibrosis and ciliary dysk-
inesias (e.g., Kartagener's syndrome) are
conditions characterized by impaired
mucociliary clearance and increased infec-
tions. Animal studies have demonstrated
that exposure to ozone inhibits pulmonary
clearance ofradiolabeled tracers and causes
increased primary allergen sensitization and
secondary anaphylaxis (24-26). Wood-
workers with high dust-exposure levels had
increased rates of impaired nasal clearance
and higher infection rates than those with
low dust-exposure levels (27).
Studies of the chronic alterations in
mucociliary clearance in upper and lower
respiratory tract disease have been inter-
preted as suggesting that loss of control of
mucociliary transport could either cause or
result from chronic respiratory disease (28).
Adverse effects of active smoking include
nonmalignant, chronic obstructive lung
disease and upper and lower respiratory
tract cancers (1,8,29). The basis for suscep-
tibility to these effects is not well under-
stood, even though numerous studies have
shown familial aggregation of chronic
obstructive lungdisease (30,31).
Our test, coupling SS exposure with
NMC, meets initial criteria for a biomarker
of susceptibility for respiratory disease
because there is a relationship to respiratory
disease and because NMC is fairly sensitive
to change after exposure to appropriate
agents (10). Additional characteristics that
would need to be determined to estimate
the utility ofNMC are its longitudinal sta-
bility and population distribution.
Interpretation of these acute smoke-
induced changes in mucociliary clearance
in terms of potential health problems is
speculative at present (10).
Understanding the mechanism of the
variability in the NMC response to acute
smoke exposure will help assess its relation-
ship to the symptoms of ETS-rhinitis,
assess whether it indicates subclinical
mucosal injury in healthy subjects, deter-
mine whether there is an altered expo-
sure-response curve, and determine if it is
a marker ofindividual susceptibility to the
chronic effects of mainstream or environ-
mental tobacco smoke.
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